Author Archives


Ph.D. student at Western University working on plant-based biopharmaceuticals. Interests include: protein engineering, synthetic biology and recombinant protein production.

Merck moves to buy Immune Design and its cancer vaccines platform for $300M

Merck is making a $300 million move to acquire Immune Design, developers of a midphase immunotherapy for non-Hodgkin’s lymphoma, as well as vaccines for respiratory syncytial virus and peanut allergies. Advertisements